Metraipolis › archive › dc_6d1326ae2bfb
In vivo CRISPR editing for cancer immunotherapy — Europe PMC PMID:42592160
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42592160
- DOI
- 10.3389/fimmu.2026.1872510
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T10:05:11.826Z
- SHA-256 of the archived text
a5c79e173c90152794542d2ec7ee0791a1df1a37757ab7556df0ddc1632ce49b- Stable URL of this page
https://metraipolis.com/documento/dc_6d1326ae2bfb
How to cite
In vivo CRISPR editing for cancer immunotherapy — Europe PMC PMID:42592160 — Europe PMC (en), https://europepmc.org/article/MED/42592160 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6d1326ae2bfb (Metraipolis archive dc_6d1326ae2bfb, sha256 a5c79e173c90152794542d2ec7ee0791a1df1a37757ab7556df0ddc1632ce49b)
BibTeX
@misc{dc6d1326ae2bfb,
title = {In vivo CRISPR editing for cancer immunotherapy — Europe PMC PMID:42592160},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42592160},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6d1326ae2bfb; sha256 a5c79e173c90152794542d2ec7ee0791a1df1a37757ab7556df0ddc1632ce49b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42592160. Agents can read the archived copy with the MCP tool read_document.